Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationCost of RevenueEBIATGross ProfitLeasesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - NetShares IssuedShares OutstandingShares Outstanding
Ratios

Arcadia Biosciences (RKDA) Other Gross PP&E Adjustments (2016 - 2025)

Arcadia Biosciences filings provide 12 years of Other Gross PP&E Adjustments readings, the most recent being $1.3 million for Q4 2025.

  • On a quarterly basis, Other Gross PP&E Adjustments rose 59.31% to $1.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $1.3 million, a 59.31% increase, with the full-year FY2025 number at $1.3 million, up 59.31% from a year prior.
  • Other Gross PP&E Adjustments hit $1.3 million in Q4 2025 for Arcadia Biosciences, down from $1.9 million in the prior quarter.
  • In the past five years, Other Gross PP&E Adjustments ranged from a high of $4.6 million in Q3 2021 to a low of -$3.4 million in Q4 2023.
  • Median Other Gross PP&E Adjustments over the past 5 years was $1.9 million (2025), compared with a mean of $1.6 million.
  • Biggest five-year swings in Other Gross PP&E Adjustments: tumbled 343.12% in 2022 and later surged 230.29% in 2024.
  • Arcadia Biosciences' Other Gross PP&E Adjustments stood at $1.2 million in 2021, then tumbled by 343.12% to -$2.9 million in 2022, then decreased by 18.5% to -$3.4 million in 2023, then surged by 124.4% to $838000.0 in 2024, then skyrocketed by 59.31% to $1.3 million in 2025.
  • The last three reported values for Other Gross PP&E Adjustments were $1.3 million (Q4 2025), $1.9 million (Q3 2025), and $1.9 million (Q2 2025) per Business Quant data.